Legacy Systems Created Operational Drag
Omeros Corporation, a clinical-stage biopharmaceutical company, was constrained by outdated ERP systems that no longer supported its evolving business needs. The company faced mounting operational costs tied to inefficient, manual back-office processes. Their legacy platform lacked the functionality required to modernize workflows, leading to redundant data entry, siloed systems, and limited visibility across departments. As the organization grew, these inefficiencies compounded—slowing decision-making and impeding scalability at a critical stage in its development.
Implementing a Scalable Cloud Solution
To overcome these challenges, Omeros deployed Oracle Fusion Cloud Financials, Procurement, and Projects. Oracle’s end-to-end cloud platform offered a scalable, future-ready solution to transform financial operations. The implementation enabled robust self-service functionality that significantly reduced administrative overhead and empowered teams to manage tasks more independently. Industry-leading best practices were embedded into budgeting and financial reporting processes, improving accuracy and control. Seamless integration with Omeros’ existing project management tools preserved business continuity while delivering new capabilities that optimized workflow efficiency.
Results: Greater Efficiency, Visibility, and Collaboration
The transformation brought immediate, organization-wide benefits. Finance and operations functions became more agile and efficient, driven by automated workflows and fewer manual touchpoints. The elimination of duplicate data entry improved data integrity and saved valuable time. Transparency increased across teams and business functions, fostering stronger collaboration and more informed strategic planning. With streamlined processes and better alignment between budgeting and execution, Omeros is now equipped to scale with greater confidence. By leveraging Oracle Cloud, the company has laid a solid foundation for long-term growth, operational excellence, and improved responsiveness in a highly dynamic and competitive biotech landscape.
